Inhalation

INH1022

Issue link: https://www.e-digitaleditions.com/i/1481142

Contents of this Issue

Navigation

Page 10 of 42

DDL2022 will take place Wednesday through Friday, December 7-9, 2022, as a live, in-person event at the Edinburgh International Conference Centre (EICC), as well as a live-streamed, virtual attendance option. Content will be delivered through presentations, posters, a technology exhibition and networking opportunities. Inhalation OctOber 2022 9 In Person and Virtually: December 7-9, 2022 Edinburgh, UK For more information: https://ddl-conference.com DDL2022 will take place Wednesday through Friday, December 7-9, 2022 as a live, in-person event at the Edinburgh International Conference Centre (EICC), as well as a live-streamed, virtual attendance option. Con- tent will be delivered through presentations, posters, a technol- ogy exhibition and networking opportunities. The DDL Lecture and session themes e prestigious DDL Annual Lec- ture will be presented by Hugh Smyth of the University of Texas. Conference themes will be: • Planetary health • Translational science • Lung diseases • e Pat Burnell Young Investigator Competition • Technology innovation • Novel formulation design and manufacture Awards and activities that sup- port new talent will include e Pat Burnell Young Investigator Competition, e DDL Emerg- ing Scientist Award and e New Researcher Network. Compli- mentary registration will be pro- vided for students. A preview of Drug Delivery to the Lungs (DDL) 2022 St. Giles Cathedral, Edinburgh, UK Trusted, Reliable Contract Development & Manufacturing renpharm.com R&D Services – Formulation – Scale-up – Stability – 2-100 mL vials – 2-100 mL vials Injectables – Multi-Dose – Unit Dose – Bi-Dose Multi-Dose – Unit Dose – Bi-Dose Nasal Renaissance develops and manufactures high-quality pharmaceuticals to fulfill your patients' needs.

Articles in this issue

Links on this page

view archives of Inhalation - INH1022